(Total Views: 411)
Posted On: 03/30/2022 2:33:50 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
I also think and hope that there will be good news, otherwise they would not have used the phrase "a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications" in the announcement.
WUM
WUM
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)